{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0011576/OMIM:605635","label":"Hyperaldosteronism, familial, type II","mondoId":"MONDO:0011576","onsetQualifier":null,"recordKeys":["a2f3bc99873738c625b7ea420468f1f6d4b0c97c5540d1c6875624f0d5317f0b","af5d608e31324f9a8a03b360d63129e20f7a5a018480d4069f43794a493aaf53","c08055c36aea476374f8720aa3745a95e11d27d97c00579e0bc816b55f4dbb0b"],"recordQualifiers":{},"scopeLabel":"OMIM:605635","sourceIds":["OMIM:605635"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0011576/ORPHA:404","label":"Familial hyperaldosteronism type II","mondoId":"MONDO:0011576","onsetQualifier":null,"recordKeys":["1ecbb80380ab4ad4d26545b7c4905d29750b8cdbcf9ed017b992778411e9c10e","1fd04e298cc2994c2b1a258e1ee5029865674922e52c370e68dd47dd81c87c19","2993abb7037d86c4e3ffefa8a38fdf86bd899ca8b242338a6b759520cc9bee44","37543ef4ec744906856b0a3172accc917ab6dde3fcd1a25cd713b432c105f036","3905c0229994206beaeb73a875eb09a3dc4cda9d0a8f3db6ea8d7ff7ab9e7a92","538f15dad9a60f9d97863316c5fc898cec141b9f45b73cf9b3441d49f0818fb8","5665bef0afb3f402c94fe92a569194a1bd6db80388f8d86fdbcef67b56217612","689a6777876c9106ddcec170fb83988434234c63724641bb0db804c5f6b981d7","76325c3465519656145c2d4bdd8d049bdbfd096cdc0227c1c81509fd45a14f56","802ddd285aff994cbaf00430556e975c1a3d01e1f155c8714ac6974deae32851","95ef2a925ef5b4fd93b5db980c5bf45d2f517f1d045baa70ac42e3e0af41b99b","995bf2a34c4d812ee00b613217c4861b2f4d060b343ee00120509eecae5a0e93","d7f0fcaed4d6b08c84a4f1bbed55add5e57139f87625fd6e69330b2d36caf74a","ead4436ce30007f4f6fbf842390a3cfc81b6bc0ff160d782773b416ec3040724"],"recordQualifiers":{},"scopeLabel":"ORPHA:404","sourceIds":["ORPHA:404"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0011576/OMIM:605635","MONDO:0011576/ORPHA:404"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":2,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":17,"sourceGroups":{"omim":0,"orphanet":14,"published":3}},"features":[{"hpoId":"HP:0040084","label":"Abnormal circulating renin concentration","primary":false},{"hpoId":"HP:0008221","label":"Adrenal hyperplasia","primary":false},{"hpoId":"HP:0011739","label":"Dexamethasone-suppressible primary hyperaldosteronism","primary":false},{"hpoId":"HP:0000421","label":"Epistaxis","primary":false},{"hpoId":"HP:0011740","label":"Glucocortocoid-insensitive primary hyperaldosteronism","primary":false},{"hpoId":"HP:0002315","label":"Headache","primary":false},{"hpoId":"HP:0000822","label":"Hypertension","primary":false},{"hpoId":"HP:0002900","label":"Hypokalemia","primary":false},{"hpoId":"HP:0000859","label":"Increased circulating aldosterone concentration","primary":false},{"hpoId":"HP:0002170","label":"Intracranial hemorrhage","primary":false},{"hpoId":"HP:0200114","label":"Metabolic alkalosis","primary":false},{"hpoId":"HP:0001324","label":"Muscle weakness","primary":false},{"hpoId":"HP:0002018","label":"Nausea","primary":false},{"hpoId":"HP:0011746","label":"Secretory adrenocortical adenoma","primary":false},{"hpoId":"HP:0000360","label":"Tinnitus","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0011576","records":[{"frequencyKind":"range","key":"1ecbb80380ab4ad4d26545b7c4905d29750b8cdbcf9ed017b992778411e9c10e","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000421","is_excluded":false,"label":"Epistaxis","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"1fd04e298cc2994c2b1a258e1ee5029865674922e52c370e68dd47dd81c87c19","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008221","is_excluded":false,"label":"Adrenal hyperplasia","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2993abb7037d86c4e3ffefa8a38fdf86bd899ca8b242338a6b759520cc9bee44","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"37543ef4ec744906856b0a3172accc917ab6dde3fcd1a25cd713b432c105f036","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011739","is_excluded":true,"label":"Dexamethasone-suppressible primary hyperaldosteronism","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3905c0229994206beaeb73a875eb09a3dc4cda9d0a8f3db6ea8d7ff7ab9e7a92","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000360","is_excluded":false,"label":"Tinnitus","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"538f15dad9a60f9d97863316c5fc898cec141b9f45b73cf9b3441d49f0818fb8","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001324","is_excluded":false,"label":"Muscle weakness","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"5665bef0afb3f402c94fe92a569194a1bd6db80388f8d86fdbcef67b56217612","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002018","is_excluded":false,"label":"Nausea","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"689a6777876c9106ddcec170fb83988434234c63724641bb0db804c5f6b981d7","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0040084","is_excluded":false,"label":"Abnormal circulating renin concentration","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"76325c3465519656145c2d4bdd8d049bdbfd096cdc0227c1c81509fd45a14f56","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"802ddd285aff994cbaf00430556e975c1a3d01e1f155c8714ac6974deae32851","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011746","is_excluded":false,"label":"Secretory adrenocortical adenoma","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"95ef2a925ef5b4fd93b5db980c5bf45d2f517f1d045baa70ac42e3e0af41b99b","raw":{"aspect":"P","body_system":"blood","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002170","is_excluded":false,"label":"Intracranial hemorrhage","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"995bf2a34c4d812ee00b613217c4861b2f4d060b343ee00120509eecae5a0e93","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0011740","is_excluded":false,"label":"Glucocortocoid-insensitive primary hyperaldosteronism","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"a2f3bc99873738c625b7ea420468f1f6d4b0c97c5540d1c6875624f0d5317f0b","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:605635","disease_name":"Hyperaldosteronism, familial, type II","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"PMID:29403012","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"af5d608e31324f9a8a03b360d63129e20f7a5a018480d4069f43794a493aaf53","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:605635","disease_name":"Hyperaldosteronism, familial, type II","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"PMID:29403012","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"c08055c36aea476374f8720aa3745a95e11d27d97c00579e0bc816b55f4dbb0b","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:605635","disease_name":"Hyperaldosteronism, familial, type II","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0000859","is_excluded":false,"label":"Increased circulating aldosterone concentration","onset_id":null,"reference":"PMID:29403011","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"d7f0fcaed4d6b08c84a4f1bbed55add5e57139f87625fd6e69330b2d36caf74a","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ead4436ce30007f4f6fbf842390a3cfc81b6bc0ff160d782773b416ec3040724","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:404","disease_name":"Familial hyperaldosteronism type II","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0200114","is_excluded":false,"label":"Metabolic alkalosis","onset_id":null,"reference":"ORPHA:404","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"familial-hyperaldosteronism-type-ii","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"familial hyperaldosteronism type II"},"schemaVersion":1}